The Use of Nirmatrelvir-ritonavir in a Case of Breakthrough Long COVID
Exploratory Research and Hypothesis in Medicine · 25.12.2023 · 000 (000) · 394-396
DOI: 10.14218/erhm.2022.00045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploratory Research and Hypothesis in Medicine, online erschienen am 13.01.2023. Verfasst von Linda N. Geng und 4 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Geng, L. N., Bonilla, H. F., Shafer, R. W., Miglis, M. G., & Yang, P. C. (2023). The Use of Nirmatrelvir-ritonavir in a Case of Breakthrough Long COVID. Exploratory Research and Hypothesis in Medicine, 000(000), 394-396. https://doi.org/10.14218/erhm.2022.00045
Vancouver
Geng LN, Bonilla HF, Shafer RW, Miglis MG, Yang PC. The Use of Nirmatrelvir-ritonavir in a Case of Breakthrough Long COVID. Exploratory Research and Hypothesis in Medicine. 2023;000(000):394-396. doi:10.14218/erhm.2022.00045
BibTeX
@article{Geng2023,
author = {Geng, Linda N. and Bonilla, Hector F. and Shafer, Robert W. and Miglis, Mitchell G. and Yang, Phillip C.},
title = {The Use of Nirmatrelvir-ritonavir in a Case of Breakthrough Long COVID},
journal = {Exploratory Research and Hypothesis in Medicine},
year = {2023},
volume = {000},
number = {000},
pages = {394--396},
doi = {10.14218/erhm.2022.00045}
}
EUVIMED